Offstream
news

The European Union and AstraZeneca reach a settlement to end a legal battle over slow delivery of the Oxford–AstraZeneca COVID-19 vaccine, with an agreement that requires AstraZeneca to deliver the remaining 200 million doses of its vaccine to the EU countries at the end of March 2022.
2021-09-3

A study from the Public Health England shows that the vaccine developed by Pfizer is 96% effective against hospitalizations from the Delta variant, while the AstraZeneca–Oxford vaccine is 92% effective.
2021-06-14

The Therapeutic Goods Administration approves the emergency use of the vaccine developed by the University of Oxford and AstraZeneca for people over 18 years of age in Australia.
2021-02-16

Supreme Leader Ali Khamenei calls for a ban on the American Pfizer and British AstraZeneca vaccines.
2021-01-8

The Netherlands begins a vaccination programme against COVID-19 with a nurse becoming the first person to be vaccinated with Pfizer's Tozinameran vaccine.
2021-01-6

The Indian government announces that the country will speed up their reviews of vaccines developed by Pfizer and AstraZeneca.
2020-12-7

AstraZeneca’s vaccine candidate shows promise in older adults. Late-stage trials are expected to be released by Christmas.
2020-11-19

AstraZeneca is expected to resume vaccine trials in the United States as early as this week.
2020-10-20

Mexican Foreign Minister Marcelo Ebrard announces the country has signed agreements with AstraZeneca for 77.4 million, COVAX for 51.57 million, CanSino Biologics for 35 million, and Pfizer for 34.4 million vaccine doses, respectively. The vaccines by Pfizer, AstraZeneca, and the COVAX plan require two doses, whereas the CanSino product requires one dose.
2020-10-13

AstraZeneca rejects the latest, and likely the last, takeover price from Pfizer, close to 70 billion pounds or US$118 billion.
2014-05-19